A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of teriflunomid (IMSE 4)Show others and affiliations
2018 (English)In: Multiple Sclerosis Journal, ISSN 1352-4585, E-ISSN 1477-0970, Vol. 24, p. 922-923Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Sage Publications, 2018. Vol. 24, p. 922-923
National Category
Neurology
Identifiers
URN: urn:nbn:se:uu:diva-369960ISI: 000446861402334OAI: oai:DiVA.org:uu-369960DiVA, id: diva2:1271648
Conference
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), OCT 10-12, 2018, Berlin, GERMANY
Funder
Swedish Research CouncilThe Swedish Brain Foundation2018-12-172018-12-172022-09-15Bibliographically approved